References
  1. Data on file; Images provided by Dr. Daniel S. Durrie; 2008.
  2. In print. Knorz M. Comparison of flap adhesion strength with the AMADEUS™ microkeratome and the IntraLase 150 kHz femtosecond laser with different side cut configurations in rabbits. J Refract Surg. 2008.
  3. Data on file; Advanced Medical Optics, Inc. Dr. Arturo S. Chayet; 2008.
  4. Data provided by Boghossian A, Durrie DS. Biomechanical comparison between Sub-Bowman's Keratomileusis and surface ablation.
  5. Stahl JE, Durrie DS, Schwendeman FJ, et al. Anterior segment OCT analysis of thin IntraLase femtosecond flaps.
    J Refract Surg. 2007;23(6):555-558.
  6. Data on file; IntraLase Corp. Durrie DS, Slade S. A prospective, randomized, multi-center clinical comparison of fellow eyes undergoing LASIK with IntraLase FS laser or photorefractive keratectomy.
  7. Kim JY, Kim MJ, Kim TI, et al. A femtosecond laser creates a stronger flap than a mechanical microkeratome. Invest Ophthalmol Vis Sci. 2006;47(2):599-604.
  8. Donnenfeld, E. Which is safer — IntraLase SMK or PRK? Presented at the IntraLase Symposium and Gala; April, 2007.
  9. Farid M, Kim M, Steinert RF. Results of penetrating keratoplasty performed with a femtosecond laser zigzag incision initial report. Ophthalmology. 2007;114(12):2208-2212.
  10. Data provided by Luciene Barbosa de Souza, MD, Hospital Oftalmologico de Sorocaba, Brazil.
  11. Submitted for publication: Yoo SH, Kymionis GD, Koreishi A, et al. Femtosecond-assisted Sutureless Anterior Lamellar Keratoplasty. Ophthalmology. 2007.
  12. Market Scope annual report; 2007.
  13. Advanced CustomVue Procedure for Monovision Clinical Trial, 2006, submitted to the FDA.
  14. Market Scope Data, U.S. Vision Population, 21 Years of Age or Older; 2005.

Laser assisted in-situ keratomileusis (LASIK) can only be performed by a trained physician and is specified for reduction or elimination of myopia, hyperopia, and astigmatism as indicated within the product labeling. Laser refractive surgery is contraindicated for patients: a) with collagen vascular, autoimmune, or immunodeficiency diseases; b) who are pregnant or nursing women; c) with signs of keratoconus or abnormal corneal topography; d) who are taking one or both of the following medications: Isotretinoin (Accutane) and Amiodarone hydrochloride (Cordarone). Potential side effects to laser refractive surgery may include glare, dry eye, as well as other visual anomalies. LASIK requires the use of a microkeratome that cuts a flap on the surface of the cornea, potential side effects may include flap related complications. Consult with your eye care professional and Patient Information Booklet regarding the potential risks and benefits for laser refractive surgery, results may vary for each individual patient.

Restricted Device: U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of a physician or other licensed eye care practitioner. U.S. Federal Law restricts the use of this device to practitioners who have been trained in its calibration and operation and who have experience in the surgical treatment and management of refractive errors.